Biopharma Buffer Market
According to Intent Market Research, the Biopharma Buffer Market is expected to grow from USD 1.5 billion in 2023 at a CAGR of 9.1% to touch USD 2.8 billion by 2030. The Biopharma Buffer Market is dominated by key players such as, Merck Group, Thermo Fisher Scientific Inc., GE Healthcare, Waters Corporation, and Agilent Technologies Inc..